Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
USE OF MARKER IN DIAGNOSING BREAST CANCER OR PREDICTING BREAST CANCER RISKS
Document Type and Number:
WIPO Patent Application WO/2024/027796
Kind Code:
A1
Abstract:
Disclosed is use of a methylation marker in diagnosing breast cancer or predicting breast cancer risks. Also disclosed is use of a reagent for detecting the methylation level of a marker in preparing a kit or a microarray for diagnosing breast cancer or predicting breast cancer risks in individuals. Further disclosed is a kit or a microarray for diagnosing breast cancer or predicting breast cancer risks in individuals.

Inventors:
SUN JIN (CN)
MA CHENGCHENG (CN)
XU MINJIE (CN)
LIU YIYING (CN)
SU ZHIXI (CN)
LIU RUI (CN)
Application Number:
PCT/CN2023/111009
Publication Date:
February 08, 2024
Filing Date:
August 03, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SINGLERA GENOMICS CHINA LTD (CN)
International Classes:
C12Q1/68
Foreign References:
US20170283886A12017-10-05
US20120172238A12012-07-05
US20190256921A12019-08-22
CN101298629A2008-11-05
CN107034295A2017-08-11
Other References:
CHEN, LING ET AL.: "Down-regulation of tumor suppressor gene FEZ1/LZTS1 in breast carcinoma involves promoter methylation and associates with metastasis", BREAST CANCER RES TREAT., vol. 116, no. 3, 31 August 2009 (2009-08-31), pages 471 - 478, XP019727895
WANG, XINXIN ET AL.: "Loss of Leucine Zipper Putative Tumor Suppressor 1 (LZTS1) Expression Contributes to Lymph Node Metastasis of Breast Invasive Micropapillary Carcinoma", PATHOL. ONCOL. RES., vol. 21, 27 March 2015 (2015-03-27), pages 1021 - 1026, XP035530316, DOI: 10.1007/s12253-015-9923-x
Attorney, Agent or Firm:
CHINA PATENT AGENT (H.K.) LTD. (CN)
Download PDF: